Page 39 - Biocon Ltd News Today

Pune-based vaccine manufacturer Serum Institute of India (SII) recorded a revenue of Rs 7201 crore during FY 20-21

/PRNewswire/ -- The global insulin syringes market size is expected to reach USD 2.69 Billion in 2030 and register a revenue CAGR of 6.9% during the forecast...

Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022

The rh-Insulin formulations, Insugen-R, Insugen-N and lnsugen-30/70, are manufactured at Biocon Sdn. Bhd.s Johor facility.

Biocon Biologics unit Biocon Sdn Bhd will make and supply its range of insulins to partner Duopharma Marketing Sdn Bhd, a subsidiary of Duopharma Biotech in Malaysia.

Business Scoop provides news and views on Business and Markets from New Zealand

Business Scoop provides news and views on Business and Markets from New Zealand

/PRNewswire/ -- The cancer biologics market share is expected to grow by USD 34.97 bn from 2021 to 2026, progressing at a CAGR of 8.91% during the forecast...

Hailing the Biocon Ltd. Executive Chairperson Kiran Mazumdar-Shaw for expressing concerns on the growing religious divide in Karnataka, Maharashtras ruling ally Nationalist Congress Party urged more Indian Inc. personalities to "speak up ...

Global Inflammatory Bowel Disease Treatment Market To Be Driven By Biosimilars In The Forecast Period Of 2021-2026